INTRODUCTION: The incidence of @entity14 ( @entity14 ) in the Czech Republic is reported to be one of the highest on the global scale. @entity5 removal has been observed to be the most effective part in the context of current multimodal therapy. The authors present their preliminary results of robotic assisted treatment of @entity189 ( @entity189 ). METHOD: The observed group includes 61 @entity1 who underwent robotic assisted treatment for @entity5 . The data were collected prospectively in the last 31 @entity1 . Analyses were conducted on epidemiological data, perioperative outcomes, complications and oncological results. RESULTS: Robotic assisted treatment of @entity189 was performed in 61 @entity1 : 34 @entity1 and 27 @entity1 , mean age of 62 years (33-80). Neoadjuvant oncological treatment was indicated in 46% of the @entity1 . Average @entity190 was 187 ml, transfusions were administered in three cases. Conversion to open procedure was performed 6 times, and 16 @entity1 had @entity260 . @entity834 was observed in 10% of the @entity1 , and 4 @entity1 undewent surgical treatment. No @entity1 died. Local recurrence of the @entity5 was diagnosed in 3 (5%) @entity1 . The quality of mesorectal excision (ME) and the circumferential resection margin [(y)pCRM] have been determined in 27 @entity1 since 2013. Positive (y)pCRM was recorded in two cases and incomplete ME was observed in 25.8% of the @entity1 . CONCLUSION: Surgical treatment for @entity189 is pivotal in multimodal therapy. Our preliminary results are similar to the conclusions in other published studies. The da Vinci robotic system is a safe manipulator in the treatment of @entity189 and provides indisputable benefits to the surgeon when operating in the narrow pelvic space. However, the benefits of robotic treatment in abdominal surgery are yet to be evaluated in @entity1 (with respect to long-term results, sufficient number of @entity1 or a high EBM level of evidence). The high purchase price of the robotic device, individual instruments with equipment and @entity262 constitute a significant hindrance that prevents wider use of the robotic system in the treatment of @entity189 and other @entity5 in the Czech Republic. KEY WORDS: @entity5 - surgical treatment - da Vinci robotic system.

[Da Vinci assisted surgery for XXXX - preliminary results of nonrandomized trial].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'men'] @entity834 :: ('MESH:D057868', 'Disease') :: ['Anastomotic leak'] @entity5 :: ('MESH:D009369', 'Disease') :: ['abdominal malignancies', 'cancer', 'Radical tumor', 'rectal cancer'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity262 :: ('MESH:D034721', 'Disease') :: ['non-systemic compensation'] @entity189 :: ('MESH:D002277', 'Disease') :: ['RC', 'rectal carcinoma'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative complications'] @entity14 :: ('MESH:D015179', 'Disease') :: ['CRC', 'colorectal cancer']
@entity5 :: (MESH:D009369,Disease) :: ['rectal cancer']
